Alnylam Pharmaceuticals, Inc. (ALNY)
236.06
-0.16
(-0.07%)
USD |
NASDAQ |
Aug 24, 16:00
237.08
+1.02
(+0.43%)
After-Hours: 19:20
Alnylam Pharmaceuticals Market Cap : 31.57B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 31.59B |
| August 20, 2026 | 30.67B |
| August 19, 2026 | 32.45B |
| August 18, 2026 | 30.57B |
| August 17, 2026 | 30.04B |
| August 14, 2026 | 30.58B |
| August 13, 2026 | 30.37B |
| August 12, 2026 | 29.95B |
| August 11, 2026 | 29.58B |
| August 10, 2026 | 29.02B |
| August 07, 2026 | 29.31B |
| August 06, 2026 | 28.90B |
| August 05, 2026 | 30.59B |
| August 04, 2026 | 29.29B |
| August 03, 2026 | 29.47B |
| July 31, 2026 | 27.49B |
| July 30, 2026 | 27.48B |
| July 29, 2026 | 38.33B |
| July 28, 2026 | 38.57B |
| July 27, 2026 | 37.23B |
| July 24, 2026 | 36.27B |
| July 23, 2026 | 35.86B |
| July 22, 2026 | 35.63B |
| July 21, 2026 | 36.21B |
| July 20, 2026 | 36.39B |
| Date | Value |
|---|---|
| July 17, 2026 | 35.69B |
| July 16, 2026 | 37.78B |
| July 15, 2026 | 37.25B |
| July 14, 2026 | 37.53B |
| July 13, 2026 | 38.44B |
| July 10, 2026 | 39.87B |
| July 09, 2026 | 41.74B |
| July 08, 2026 | 43.17B |
| July 07, 2026 | 42.91B |
| July 06, 2026 | 41.77B |
| July 02, 2026 | 41.74B |
| July 01, 2026 | 40.26B |
| June 30, 2026 | 40.17B |
| June 29, 2026 | 39.17B |
| June 26, 2026 | 38.88B |
| June 25, 2026 | 39.12B |
| June 24, 2026 | 39.24B |
| June 23, 2026 | 38.46B |
| June 22, 2026 | 38.22B |
| June 18, 2026 | 37.11B |
| June 17, 2026 | 37.73B |
| June 16, 2026 | 37.62B |
| June 15, 2026 | 38.41B |
| June 12, 2026 | 37.74B |
| June 11, 2026 | 38.62B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ionis Pharmaceuticals, Inc. | 10.27B |
| Regeneron Pharmaceuticals, Inc. | 85.69B |
| Vertex Pharmaceuticals, Inc. | 138.77B |
| BridgeBio Pharma, Inc. | 15.83B |
| Pfizer Inc. | 159.46B |
Market Cap Related Metrics
| PE Ratio | 39.86 |
| PS Ratio | 6.758 |
| Price to Book Value | 23.31 |
| Price to Free Cash Flow | 40.89 |
| Price | 236.06 |
| Earnings Yield | 2.51% |
| Operating PE Ratio | 32.47 |
| Normalized PE Ratio | 41.01 |